Business / Finance

RSS

Roche grants in vitro diagnostics product license for real-time PCR technology to LTC

Roche and Life Technologies Corporation announced today that they have entered into two license agreements to allow LTC to expand its PCR offerings for diagnostics applications.

23 Feb 2012

Healthcare Realty Trust reports total revenues of $76.4M for fourth quarter 2011

Healthcare Realty Trust Incorporated today announced results for the fourth quarter ended December 31, 2011. Normalized FFO for the three months ended December 31, 2011 totaled $0.33 per diluted common share.

23 Feb 2012

Onyx reports total operating revenue of $237.0M for fourth quarter 2011

Onyx Pharmaceuticals, Inc. today reported its financial results for the full year and fourth quarter 2011. Onyx reported non-GAAP net income of $42.0 million, or $0.66 per diluted share, for the full year 2011 compared to non-GAAP net income of $39.2 million, or $0.63 per diluted share, for the same period in 2010.

23 Feb 2012

Express Scripts fourth quarter gross profit increases 8% to $0.9 billion

Express Scripts, Inc. announced 2011 fourth quarter and full year net income from continuing operations of $290.4 million and $1,275.8 million, or $0.59 and $2.53 per diluted share, respectively.

23 Feb 2012

Volcano fourth quarter revenues increase 14% to $92.7 million

Volcano Corporation, a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today said revenues in the fourth quarter of 2011 increased 14 percent versus the fourth quarter of 2010.

23 Feb 2012

MannKind net loss for 2011 decreases to $160.8 million

MannKind Corporation today reported financial results for the fourth quarter and year ended December 31, 2011.

23 Feb 2012

Dyax fourth quarter total revenues decrease to $8.5 million

Dyax Corp. today announced financial results for the fourth quarter and year ended December 31, 2011.

22 Feb 2012

CardioNet fourth quarter revenue decreases 6.6% to $26.8 million

CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the fourth quarter and full year-ended December 31, 2011.

22 Feb 2012

Questcor fourth quarter net sales increase to $75.5 million

Questcor Pharmaceuticals, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2011.

22 Feb 2012

Publicis Groupe acquires UBS

Publicis Groupe announced today that it has acquired U-Link Business Solutions Co. Ltd (UBS), one of the leading Chinese agencies specialized in healthcare communications.

22 Feb 2012

Mylan receives $300M committed financing

Mylan Inc. today announced that it has entered into a facility agreement with a syndicate of banks to securitize up to $300 million of U.S. accounts receivable. The facility is committed and has a maturity of three years. The interest rate on any outstanding borrowings will be more than 100 basis points lower than the rate on the company's secured credit facilities.

21 Feb 2012

GTx fourth quarter net loss increases to $10.7 million

GTx, Inc. today provided a Company update and reported financial results for the fourth quarter and full year 2011.

21 Feb 2012

Medco fourth-quarter total net revenues increase 12.2% to record $19.0 billion

Medco Health Solutions, Inc. today reported record fourth-quarter 2011 GAAP diluted EPS of $1.08, an increase of 22.7 percent, which includes expenses associated with the pending merger with Express Scripts, Inc. of $43.6 million before provision for income taxes. When excluding these merger-related expenses, diluted EPS increased 29.5 percent over fourth-quarter 2010.

21 Feb 2012

Cadila Pharmaceuticals to distribute Bactiguard products throughout India

Bactiguard has signed an exclusive co-operation with Cadila Pharmaceuticals, one of the largest healthcare manufacturing groups in India. A signing process will take place at the Swedish Ambassador's residency tonight.

21 Feb 2012

Flaws in ESI-Medco efficiency claims over proposed merger

David A. Balto, an antitrust attorney in Washington and former Policy Director of the Federal Trade Commission, released a white paper today exposing the flaws in efficiency claims made by Express Scripts, Inc. and Medco Health Solutions, Inc. with respect to their proposed merger.

20 Feb 2012

ICA reports a year full of achievements

ICA announced today that 2011 saw strong growth in hospitals and clinics under contract for its CareAlign Solutions suite, as well as significant product upgrades among its current client base. In addition, ICA's employee base again nearly doubled in 2011 to meet growing demand and critical partnerships were formalized.

20 Feb 2012

Mobius selects The Apothecary Shops as distribution partner for Mitosol Kit for Ophthalmic Use

Apothecary Shop Wholesale, Inc., an affiliate of The Apothecary Shops Specialty Pharmacies, has received exclusive distribution rights from Mobius Therapeutics, LLC for its new drug Mitosol (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use.

18 Feb 2012

Provena Health and Resurrection Health Care are now joined as Presence Health

Presence Health has been chosen as the name of the new healthcare system formed by the November 2011 merger of Provena Health of Mokena, IL, and Resurrection Health Care of Chicago, IL. A formal rollout of a new logo and related branding will occur over the next several months.

18 Feb 2012

NASDAQ notifies CytRx of non-compliance with minimum bid price requirement

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that, as anticipated, on February 15, 2012, the Company was notified by The NASDAQ Stock Market that because the Company has not regained compliance with the $1.00 minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2), the Company's common stock would be subject to delisting from The NASDAQ Capital Market unless the Company requests a hearing before a NASDAQ Hearings Panel.

18 Feb 2012

Cardinal Health Canada's offer for Futuremed common shares expires

Cardinal Health Canada Inc., a wholly-owned subsidiary of Cardinal Health, Inc., announced today that the offer by Cardinal Health Canada to acquire all of the outstanding common shares of Futuremed Healthcare Products Corporation for CAD $8.15 per Common Share in cash has expired.

18 Feb 2012